Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

Lignende værker

• Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy
  af: Aoyama, Toru, et al.
  Udgivet: (2017)
• Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy
  af: Murakawa, Masaaki, et al.
  Udgivet: (2017)
• The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection
  af: Murakawa, Masaaki, et al.
  Udgivet: (2019)
• The short- and long-term outcomes of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas
  af: Murakawa, Masaaki, et al.
  Udgivet: (2015)
• Evaluation of safety, feasibility and the long-term outcomes of colorectomy for colorectal adenocarcinoma in patients older than 80 years of age
  af: Yukawa, Norio, et al.
  Udgivet: (2017)